A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
Barosi
Giovanni
G
Birgegard
Gunnar
G
Finazzi
Guido
G
Griesshammer
Martin
M
Harrison
Claire
C
Hasselbalch
Hans
H
Kiladijan
Jean-Jacques
JJ
Lengfelder
Eva
E
Mesa
Ruben
R
Mc Mullin
Mary F
MF
Passamonti
Francesco
F
Reilly
John T
JT
Vannucchi
Alessandro M
AM
Barbui
Tiziano
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003245:Consensus Statements as Topic; D004351:Drug Resistance; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D009626:Terminology as Topic
D000970:Antineoplastic Agents; D006918:Hydroxyurea